Prime Medicine, Inc. (PRME)
4.255
+0.36
(+9.38%)
USD |
NASDAQ |
Nov 13, 16:00
4.255
0.00 (0.00%)
After-Hours: 19:59
Prime Medicine Market Cap : 769.04M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 703.07M |
| November 11, 2026 | 777.17M |
| November 10, 2026 | 704.88M |
| November 09, 2026 | 777.17M |
| November 06, 2026 | 840.43M |
| November 05, 2026 | 804.28M |
| November 04, 2026 | 898.27M |
| November 03, 2026 | 822.36M |
| November 02, 2026 | 802.47M |
| October 30, 2026 | 853.08M |
| October 29, 2026 | 947.06M |
| October 28, 2026 | 968.75M |
| October 27, 2026 | 786.21M |
| October 26, 2026 | 652.46M |
| October 23, 2026 | 663.31M |
| October 22, 2026 | 674.15M |
| October 21, 2026 | 688.61M |
| October 20, 2026 | 708.49M |
| October 19, 2026 | 692.22M |
| October 16, 2026 | 627.16M |
| October 15, 2026 | 652.46M |
| October 14, 2026 | 565.71M |
| October 13, 2026 | 600.05M |
| October 12, 2026 | 652.46M |
| October 09, 2026 | 721.14M |
| Date | Value |
|---|---|
| October 08, 2026 | 647.04M |
| October 07, 2026 | 704.88M |
| October 06, 2026 | 632.58M |
| October 05, 2026 | 580.17M |
| October 02, 2026 | 538.60M |
| October 01, 2026 | 540.41M |
| September 30, 2026 | 552.15M |
| September 29, 2026 | 558.48M |
| September 28, 2026 | 519.62M |
| September 25, 2026 | 524.14M |
| September 24, 2026 | 554.86M |
| September 23, 2026 | 565.71M |
| September 22, 2026 | 639.81M |
| September 21, 2026 | 576.55M |
| September 18, 2026 | 563.90M |
| September 17, 2026 | 567.52M |
| September 16, 2026 | 542.21M |
| September 15, 2026 | 567.52M |
| September 14, 2026 | 574.75M |
| September 11, 2026 | 565.71M |
| September 10, 2026 | 605.47M |
| September 09, 2026 | 627.16M |
| September 08, 2026 | 643.43M |
| September 04, 2026 | 668.73M |
| September 03, 2026 | 670.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.361B |
| Beam Therapeutics, Inc. | 2.364B |
| Twist Bioscience Corp. | 6.992B |
| Moderna, Inc. | 90.17B |
| Q32 Bio, Inc. | 260.66M |
Market Cap Related Metrics
| PS Ratio | 181.60 |
| Price to Book Value | 19.32 |
| Price | 4.255 |
| Earnings Yield | -25.51% |